Medibig SRL
Medibig reported total assets of 415,605 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Medibig shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets +39 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medibig's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 74,351 € | ||||
| Equity | 407,065 € | ||||
| Cash | 361,950 € | ||||
| EBITDA | 115,285 € | ||||
| Total assets | 415,605 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Medibig's financial analysis
- Solvency97.9%sector median: 48.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medibig
Medibig's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0889.602.143
- VAT number
- BE0889602143
- Peppol
- Registered · 0208:0889602143 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 May 2007
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Activities in the field of nutrition (NACE 86995)
Medibig (SRL) has been based in Uccle since 2007, active in: activities in the field of nutrition. For 2025, it reports a net profit of 74,351 € and equity of 407,065 €; its revenue is not published. Its solvency stands at 97.9%, above the median of its sector (48.0%).
Companies similar to Medibig
Companies in the same business, of comparable size and area, outside its group.
- Dokter Baesberg,Algemene Geneeskunde Other human health activities n.e.c. Sint-Pieters-Leeuw · balance sheet 557,932 €
- Vrijdaghs Johan Other human health activities n.e.c. Willebroek · balance sheet 386,028 €
- Sogamed Other human health activities n.e.c. Theux · balance sheet 359,699 €
- Dokterspraktijk Knaepen Chantal Other human health activities n.e.c. Tervuren · balance sheet 332,776 €
- Societe DE Cardiologie ET Consultance Medicale Other human health activities n.e.c. Koekelberg · balance sheet 552,645 €
- Docteur A. Corbisier Other human health activities n.e.c. Écaussinnes · balance sheet 633,627 €
- Europees Economisch Samenwerkingsverband Voor Homeopathischeen Antroposofische Medische Producten Other human health activities n.e.c. Brussels · balance sheet 152,210 €
- NK Consult Other human health activities n.e.c. Brussels · balance sheet 2,878 €
Frequently asked questions about Medibig
What is the revenue of Medibig?
Medibig files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medibig?
In Belgium, the VAT number is the company number prefixed with BE: BE0889602143 for Medibig, if the company is VAT-registered. Its company number (CBE) is 0889.602.143.
Where is the registered office of Medibig?
According to the CBE register, the registered office of Medibig is in 1180 Uccle.
What is the equity of Medibig?
At the close of the 2025 financial year, the equity of Medibig amounts to 407,065 €, a solvency of 97.9% of total assets.
Who manages Medibig?
The register lists 1 active mandates at Medibig. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medibig
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →